Some patients need momentum before they can build habits. They have been stuck long enough that the psychological weight of repeated failed attempts is as much of an obstacle as the biological one. They need to see the scale move. They need to feel what progress feels like before they can sustain it.
Phentermine was built for that patient.
It is the most prescribed weight loss medication in the United States. It has been FDA-approved for over 60 years. It works fast, it works clearly, and under proper medical supervision it gives patients the early traction that makes the rest of the work possible.
At South Beach Wellness Center, Maribel Dixon, MSN, APRN FNP-C offers provider-supervised phentermine therapy for appropriate adult patients in Wesley Chapel, Land O’ Lakes, Lutz, and New Tampa. Every prescription is preceded by a full health history review, physical exam, and lab work. Every patient is monitored throughout treatment. Phentermine at South Beach Wellness Center is a medically managed protocol, not a prescription handed out after a five-minute conversation.
Maribel Dixon, MSN, APRN FNP-C
Phentermine is an FDA-approved prescription appetite suppressant in the sympathomimetic amine class. It stimulates the central nervous system to release norepinephrine, a neurotransmitter that signals the brain to reduce hunger and increase energy expenditure.
The result is a meaningful and relatively rapid reduction in appetite, increased energy, and a decreased preoccupation with food that gives patients the behavioral window they need to establish new eating patterns and begin losing weight.
It is approved for short-term use, typically eight to twelve weeks, in conjunction with a reduced-calorie diet and increased physical activity. It is not a standalone solution. It is a tool that creates the conditions for the patient to build the habits and lifestyle changes that sustain results beyond the medication window.
Phentermine has been studied and prescribed longer than any other weight loss medication currently in use. Its efficacy, side effect profile, and appropriate patient selection criteria are well understood.
Phentermine works primarily through the central nervous system rather than the hormonal and metabolic pathways targeted by GLP-1 medications.
Phentermine stimulates the release of norepinephrine in the hypothalamus, the brain region controlling hunger and satiety. Elevated norepinephrine signals the body that it is in a state of heightened alertness, which suppresses appetite through the same physiological pathway activated during the fight-or-flight response. The practical effect is a significant and relatively immediate reduction in hunger. Unlike GLP-1 medications, which reduce appetite gradually over a titration period of weeks to months, phentermine produces noticeable appetite suppression within the first few days of use for most patients.
The sympathomimetic effect of phentermine also increases energy and metabolic rate. Patients commonly report feeling more alert and energetic during treatment, which supports the increased physical activity that amplifies weight loss results and helps preserve muscle mass during caloric restriction.
Behavioral Window
The appetite suppression and energy increase phentermine produces create what is best understood as a behavioral window: a period during which establishing new eating patterns, portion habits, and activity routines is significantly easier than it would be without the medication's support.
The patients who achieve the most durable results from phentermine are those who use this window intentionally, building habits during treatment that do not depend on the medication to maintain after it ends.
Phentermine and GLP-1 medications like semaglutide and tirzepatide are both effective weight loss tools, but they are not interchangeable. They work through entirely different mechanisms, produce different magnitudes of weight loss, carry different side effect profiles, and suit different patients.
Phentermine works through central nervous system stimulation. GLP-1 medications work through hormonal and metabolic pathways.
Phentermine produces appetite suppression within days. GLP-1 medications build over a titration period of weeks to months.
Phentermine is approved for short-term use, typically eight to twelve weeks. GLP-1 medications are designed for ongoing chronic disease management.
Clinical data on GLP-1 medications shows greater average weight loss over longer treatment periods. Phentermine produces meaningful short-term results but does not match the sustained outcomes of tirzepatide or semaglutide over twelve months or more.
Phentermine suits patients who need immediate momentum, patients for whom GLP-1 medications are not appropriate or available, patients bridging to a GLP-1 program, and patients who have responded well to phentermine previously.
Phentermine is significantly less expensive than GLP-1 medications. For patients for whom cost is a determining factor, phentermine provides medically supervised weight loss support at a fraction of the price.
Maribel reviews your full clinical picture at your consultation and makes a specific recommendation. The right medication is the one that fits your health history, your goals, your tolerance profile, and your situation, not the one with the most current attention.
Phentermine is appropriate for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition, who do not have contraindications to sympathomimetic medications.
Phentermine tends to be the strongest fit for:
Patients who need fast initial results to build confidence and momentum. Patients who cannot access or afford GLP-1 medications. Patients bridging to a GLP-1 program while navigating availability or prior authorization. Patients with a prior positive response to phentermine. Patients for whom the short-term supervised use model fits their situation better than an ongoing chronic medication program.
Phentermine is not appropriate for:
Patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, or a history of drug abuse. Patients currently taking or who have recently taken MAO inhibitors. Patients who are pregnant or breastfeeding. Patients with a history of pulmonary hypertension or valvular heart disease.
These contraindications are evaluated thoroughly at your consultation. Maribel does not prescribe phentermine without reviewing your cardiovascular history, current medications, and relevant health background.
Your consultation includes a full health history review with specific attention to cardiovascular health and current medications, a physical exam including blood pressure measurement, and baseline lab work. The lab panel establishes your metabolic baseline and screens for conditions that affect candidacy. Body composition is assessed using our seca mBCA Alpha body composition analyzer. Your baseline visceral fat, skeletal muscle mass, body fat percentage, and phase angle are recorded so subsequent scans show exactly what is changing.
Phentermine is prescribed at the appropriate dose for your situation. Maribel provides specific guidance on timing, nutrition, and activity to maximize results during the treatment window. The behavioral component of the protocol is not an afterthought. It is the piece that determines whether your results last beyond the medication period.
Blood pressure and cardiovascular status are monitored throughout treatment. Side effects are reviewed at each visit. Body composition scans track changes in fat mass and lean tissue. If phentermine is not producing adequate response or if side effects warrant a change, Maribel adjusts the protocol.
Because phentermine is approved for short-term use, planning for what comes after is part of the protocol from the beginning. For some patients, the habits built during treatment are sufficient to maintain results. For others, transitioning to a GLP-1 medication after the phentermine course provides continuity of medical support. Maribel discusses this at your initial consultation and revisits it as you approach the end of your treatment window.
Phentermine’s side effect profile reflects its stimulant mechanism. The most common effects are:
The most clinically significant monitoring concern. Maribel checks blood pressure at follow-up visits throughout treatment. Patients with borderline blood pressure at baseline are monitored more closely.
Phentermine's appetite-suppressing effect can diminish over time, which is one of the primary reasons it is approved for short-term use rather than ongoing chronic management. This is a normal pharmacological response and part of why the short-term supervised protocol model exists.
A common early side effect, particularly if phentermine is taken too late in the day. Taking it early in the morning and avoiding caffeine reduces this significantly for most patients.
Extremely common and manageable. Adequate hydration addresses it for most patients.
Related to the sympathomimetic mechanism. Generally mild in appropriate patients but monitored throughout treatment.
Some patients experience mood elevation or irritability. If significant, Maribel adjusts the protocol.
Most side effects are manageable and improve over the first few weeks as the body adjusts. Patients experiencing side effects that affect their quality of life or safety should contact Maribel directly rather than discontinuing abruptly.
Phentermine is a starting point, not a complete solution. The patients who maintain the most weight loss after a phentermine course are those who used the treatment window to build sustainable habits rather than relying on the medication alone.
Maribel builds a post-phentermine plan into every protocol from the beginning. Depending on your situation, your goals, and your response to treatment, that plan may involve transitioning to a GLP-1 medication for ongoing medical support, maintaining with lifestyle strategies built during treatment, or a combination approach using NOM therapy to address craving and emotional eating patterns after the stimulant phase ends.
Weight regain after phentermine discontinuation is common in patients who did not establish sustainable behavioral changes during treatment. Acknowledging that reality at the outset, and planning for it, is part of what separates medically supervised phentermine therapy from a prescription handed out with no follow-up.
Is phentermine safe?
Phentermine has been FDA-approved for over 60 years and has one of the most thoroughly understood safety profiles of any weight loss medication. It is safe for appropriate patients under medical supervision with proper monitoring. It is not appropriate for patients with cardiovascular conditions, uncontrolled hypertension, or other contraindications, which is why a thorough health review before prescribing is non-negotiable.
How quickly does phentermine work?
Most patients notice meaningful appetite reduction within the first few days of use. Measurable weight loss typically begins within the first one to two weeks. The speed of effect is one of phentermine’s primary clinical advantages over GLP-1 medications for patients who need early momentum.
How long can I take phentermine?
Phentermine is FDA-approved for short-term use, typically eight to twelve weeks. Some providers prescribe it for longer periods with appropriate monitoring, but extended use is associated with tolerance development and is not standard protocol. Maribel discusses duration at your consultation based on your individual situation.
Can I take phentermine with other weight loss medications?
Phentermine can be combined with certain other medications under careful medical supervision. It is contraindicated with MAO inhibitors and requires caution with other stimulants. Maribel reviews all current medications before prescribing. The combination of phentermine with topiramate is an established protocol available by prescription as Qsymia, which Maribel can discuss if appropriate.
Will I regain weight after stopping phentermine?
Without sustainable behavioral changes established during treatment, weight regain is common after discontinuation. This is why the behavioral component of the protocol matters and why post-phentermine planning is part of every protocol Maribel manages.
Can I transition from phentermine to a GLP-1 medication?
Yes. Some patients use phentermine to generate initial momentum while waiting for GLP-1 access or insurance approval, then transition to semaglutide or tirzepatide for longer-term management. Maribel can manage that transition and design a protocol that covers both phases.
Is phentermine less expensive than GLP-1 medications?
Yes, significantly. Phentermine is a generic medication available at very low cost at most pharmacies. For patients for whom the cost of GLP-1 medications is a barrier, phentermine provides meaningful medically supervised weight loss support at a fraction of the price.
Do you prescribe phentermine via telehealth?
Florida telehealth regulations and DEA requirements for controlled substance prescribing govern phentermine prescribing via telehealth. Contact our office to discuss your specific situation and whether an in-person or virtual visit is appropriate for your initial consultation.
Schedule a medical weight loss consultation with Maribel Dixon, MSN, APRN FNP-C at South Beach Wellness Center. Maribel will review your full health picture and tell you directly whether phentermine is the right fit, whether a GLP-1 program is the stronger option, or whether a combined approach makes the most sense for your situation.
